Literature DB >> 19083297

Hemolytic anemia from ceftriaxone in an elderly patient: a case report.

Syed Nasrat Imam1, Khadijah Wright, Nirmala Bhoopalam, Abdul Choudhury.   

Abstract

Hemolytic anemia is uncommon in the general population; however, drug-induced hemolysis is not rare in hospitalized patients. We report a case of unrecognized subacute hemolytic anemia due to ceftriaxone in a geriatric patient requiring multiple blood transfusions before a correct diagnosis could be established.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 19083297     DOI： 10.1016/j.jamda.2008.05.001

Source DB:  PubMed          Journal:  J Am Med Dir Assoc        ISSN： 1525-8610            Impact factor:   4.669


  4 in total

1.  Development of Delayed Hemolytic Anemia After Treatment with Oral Artemether-Lumefantrine in Two Patients with Severe Falciparum Malaria.

Authors:  Yasuhiro Tsuchido; Fukumi Nakamura-Uchiyama; Kasumi Toyoda; Moritoshi Iwagami; Kentaro Tochitani; Koh Shinohara; Naokuni Hishiya; Taku Ogawa; Kenji Uno; Kei Kasahara; Yukiteru Ouji; Shigeyuki Kano; Keiichi Mikasa; Tsunehiro Shimizu; Masahide Yoshikawa; Haruhiko Maruyama
Journal:  Am J Trop Med Hyg       Date:  2017-02-13       Impact factor: 2.345

Review 2.  Outpatient parenteral antimicrobial therapy with ceftriaxone, a review.

Authors:  Christopher J A Duncan; David A Barr; R Andrew Seaton
Journal:  Int J Clin Pharm       Date:  2012-04-17

3.  Ceftriaxone-Induced Hemolytic Anemia in a Jehovah's Witness.

Authors:  James Tasch; Pedro Gonzalez-Zayaz
Journal:  Am J Case Rep       Date:  2017-04-21

4.  Cefazolin-induced hemolytic anemia: a case report and systematic review of literature.

Authors:  Elizabeth Mause; Mohammad Selim; Manasa Velagapudi
Journal:  Eur J Med Res       Date:  2021-11-24       Impact factor: 2.175
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.